Melasma Archives - JDDonline - Journal of Drugs in Dermatology

Skin of Color Update 30% Off Registration, Use Code: JDD30

Oct 09

Efficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Post-inflammatory Hyperpigmentation

By Mikaela Sonis Featured Articles, Latest News, Melasma, Video Abstract

New Video Abstract Featuring Pearl Grimes, MD, FAAD, Department of Dermatology, University of California, Los Angeles. Hyperpigmentation is characterized by uneven skin tone, commonly due to excess melanin production.1 Hyperpigmentation is…

Jul 10

Love5

July Is Hyperpigmentation and Melasma Awareness Month

By Matt Breeman Dyspigmentation, Featured Articles, Latest News, Melasma

July Is Hyperpigmentation & Melasma Awareness Month – Did You Know We Have a Curated Resource Just for You? As summer sun peaks, so does your patients' concern about dark…

Jun 25

Love3

World Vitiligo Day

By courtney cruickshank Dyspigmentation, Featured Articles, Latest News, Melasma, Skin of Color, The Latest, Vitiligo

June 25 marks World Vitiligo Day, a global recognition of a condition that affects approximately 0.5-2% of the population worldwide. Though non-life-threatening, vitiligo carries a profound psychosocial burden, disproportionately affecting…

Aug 19

Love9

JDD in the News: Racial and Ethnic Minority Underrepresentation in Vitiligo Clinical Trials; Combination Cream for Melasma

By Matt Breeman Atopic Dermatitis, Featured Articles, JDD Highlights, JDD in the Media, Melasma, Skin Cancer, Skin of Color, The Latest

by Allison Sit Managed Healthcare Executive and Healio both wrote about a JDD study on the underrepresentation of racial and ethnic minority groups in vitiligo research. The study, “Racial and…

Mar 26

Love8

JDD in the News: Cysteamine Isobionic-Amide Complex for Melasma

By Matt Breeman Atopic Dermatitis, Featured Articles, JDD Highlights, JDD in the Media, Melasma, The Latest

by Allison Sit Dermatology Advisor, Dermatology Times and Healio all covered recent articles in the Journal of Drugs in Dermatology. One study, “Cysteamine Isobionic-Amide Complex Versus Kligman’s Formula for the…

Aug 03

Love9

WATCH VIDEO ABSTRACT: Scarring and Dyschromias in Fitzpatrick Skin Type IV-VI: A Review of Dermatologic Treatment Protocols

By Krista Reznik Featured Articles, JDD Highlights, Melasma, Skin of Color, The Latest

Click Here to View Video Abstract Importance: Managing chronic conditions is an essential aspect of dermatologic care, especially regarding the resolution of inflammatory dermatologic disease and recovery of skin lesions. Short-term…

May 18

Love4

JDD in the News: Vitiligo and Comorbidities, Topical Tranexamic Acid for Melasma

By Krista Reznik Featured Articles, JDD Highlights, JDD in the Media, Melasma, Skin of Color, The Latest

The dermatology trade press featured several JDD articles about pigmentary disorders in recent weeks. Dermatology Times reported on a JDD study in its article about comorbidities in vitiligo. The study,…

Apr 12

Love4

The Many Faces of Melasma

By Krista Reznik Derm Community, Inclusive Dermatology Atlas, Melasma

Melasma is a dermatologic condition that causes brown or gray patches to appear on the skin, typically on the face, neck, chest, and arms. It is a chronic condition that…

Melasma

Efficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Post-inflammatory Hyperpigmentation

July Is Hyperpigmentation and Melasma Awareness Month

World Vitiligo Day

JDD in the News: Racial and Ethnic Minority Underrepresentation in Vitiligo Clinical Trials; Combination Cream for Melasma

JDD in the News: Cysteamine Isobionic-Amide Complex for Melasma

WATCH VIDEO ABSTRACT: Scarring and Dyschromias in Fitzpatrick Skin Type IV-VI: A Review of Dermatologic Treatment Protocols

JDD in the News: Vitiligo and Comorbidities, Topical Tranexamic Acid for Melasma

The Many Faces of Melasma

Advertisement

Dermatology Topics

Advertisement

Top News Stories

News Topics

Journal of Drugs in Dermatology

Search